RETRACTED: Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis.

Ghiassian SD, Withers JB, Santolini M, Saleh A, Akmaev VR

Open source

DOI
10.1016/j.trsl.2021.04.010
Published
2022 Jan
Container
Translational research : the journal of laboratory and clinical medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.trsl.2021.04.010,
  title = {RETRACTED: Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis.},
  author = {Ghiassian SD and Withers JB and Santolini M and Saleh A and Akmaev VR},
  year = {2022},
  journal = {Translational research : the journal of laboratory and clinical medicine},
  doi = {10.1016/j.trsl.2021.04.010},
  url = {https://doi.org/10.1016/j.trsl.2021.04.010}
}

RIS

TY  - JOUR
TI  - RETRACTED: Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis.
AU  - Ghiassian SD
AU  - Withers JB
AU  - Santolini M
AU  - Saleh A
AU  - Akmaev VR
PY  - 2022
JO  - Translational research : the journal of laboratory and clinical medicine
DO  - 10.1016/j.trsl.2021.04.010
UR  - https://doi.org/10.1016/j.trsl.2021.04.010
ER  - 

APA

SD, G., JB, W., M, S., A, S., & VR, A. (2022). RETRACTED: Network-based response module comprised of gene expression biomarkers predicts response to infliximab at treatment initiation in ulcerative colitis.. Translational research : the journal of laboratory and clinical medicine. https://doi.org/10.1016/j.trsl.2021.04.010

Source records